GE Healthcare anticipates demand with Swiss facility investment
GE Healthcare reacts to the number of regenerative medicine companies operating globally by announcing plans for a facility to create single-use kits and advanced therapies.
GE Healthcare reacts to the number of regenerative medicine companies operating globally by announcing plans for a facility to create single-use kits and advanced therapies.
WCG adds to its portfolio of solutions for clinical trial sponsors by acquiring Statistics Collaborative.
PACT Pharma reels in Series C financing round to support expansion of cell therapy manufacturing capacity.